Bayesian Multiclass Classification of Gene Expression Colorectal Cancer Stages

[1]  T. Ørntoft,et al.  Classification of Dukes' B and C colorectal cancers using expression arrays , 2003, Journal of Cancer Research and Clinical Oncology.

[2]  I. Yang,et al.  Molecular staging for survival prediction of colorectal cancer patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  C. Ko,et al.  Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. , 2005, Journal of the National Cancer Institute.

[4]  T. Tahara,et al.  Influence of HRH2 promoter polymorphism on aberrant DNA methylation of DAPK and CDH1 in the gastric epithelium , 2013, BMC Gastroenterology.

[5]  Monika Simjanoska,et al.  Bayesian posterior probability classification of colorectal cancer probed with Affymetrix microarray technology , 2013, 2013 36th International Convention on Information and Communication Technology, Electronics and Microelectronics (MIPRO).

[6]  S. Bonin,et al.  Management of stage II colon cancer - the use of molecular biomarkers for adjuvant therapy decision , 2013, BMC Gastroenterology.

[7]  Hiroshi Tanaka,et al.  Clinical Significance of Osteoprotegerin Expression in Human Colorectal Cancer , 2011, Clinical Cancer Research.

[8]  K. Jain,et al.  Applications of biochips: from diagnostics to personalized medicine. , 2004, Current opinion in drug discovery & development.

[9]  T. Ørntoft,et al.  Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer , 2009, Clinical Cancer Research.

[10]  G. Orphanides,et al.  Subtypes of primary colorectal tumors correlate with response to targeted treatment in colorectal cell lines , 2012, BMC Medical Genomics.

[11]  L. V. van't Veer,et al.  Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  Zhijin Wu,et al.  Subset Quantile Normalization Using Negative Control Features , 2010, J. Comput. Biol..

[13]  D. Birnbaum,et al.  A seven-gene signature aggregates a subgroup of stage II colon cancers with stage III. , 2012, Omics : a journal of integrative biology.

[14]  J. Mesirov,et al.  Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Farid E Ahmed,et al.  Molecular Cancer BioMed Central Review , 2005 .

[16]  Lu Xie,et al.  DigOut: viewing differential expression genes as outliers. , 2010, Journal of bioinformatics and computational biology.

[17]  Thomas Downey,et al.  A ‘metastasis-prone’ signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics , 2010, Clinical & Experimental Metastasis.